1
|
Lewis CE, Pickering B. Livestock and Risk Group 4 Pathogens: Researching Zoonotic Threats to Public Health and Agriculture in Maximum Containment. ILAR J 2022; 61:86-102. [PMID: 34864994 PMCID: PMC8759435 DOI: 10.1093/ilar/ilab029] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2020] [Revised: 09/12/2021] [Accepted: 09/27/2021] [Indexed: 11/17/2022] Open
Abstract
Maximum-containment laboratories are a unique and essential component of the bioeconomy of the United States. These facilities play a critical role in the national infrastructure, supporting research on a select set of especially dangerous pathogens, as well as novel, emerging diseases. Understanding the ecology, biology, and pathology at the human-animal interface of zoonotic spillover events is fundamental to efficient control and elimination of disease. The use of animals as human surrogate models or as target-host models in research is an integral part of unraveling the interrelated components involved in these dynamic systems. These models can prove vitally important in determining both viral- and host-factors associated with virus transmission, providing invaluable information that can be developed into better risk mitigation strategies. In this article, we focus on the use of livestock in maximum-containment, biosafety level-4 agriculture (BSL-4Ag) research involving zoonotic, risk group 4 pathogens and we provide an overview of historical associated research and contributions. Livestock are most commonly used as target-host models in high-consequence, maximum-containment research and are routinely used to establish data to assist in risk assessments. This article highlights the importance of animal use, insights gained, and how this type of research is essential for protecting animal health, food security, and the agriculture economy, as well as human public health in the face of emerging zoonotic pathogens. The utilization of animal models in high-consequence pathogen research and continued expansion to include available species of agricultural importance is essential to deciphering the ecology of emerging and re-emerging infectious diseases, as well as for emergency response and mitigation preparedness.
Collapse
Affiliation(s)
- Charles E Lewis
- Corresponding Author: Dr Charles E. Lewis, DVM, MPH, MS, National Centre for Foreign Animal Diseases, Canadian Food Inspection Agency, 1015 Arlington Street, Winnipeg, Manitoba, R3E 3M4, Canada. E-mail:
| | | |
Collapse
|
2
|
Kharchenko GA, Kimirilova OG. Clinical and epidemiological characteristics of measles in the Astrakhan region in 2013–2019. ROSSIYSKIY VESTNIK PERINATOLOGII I PEDIATRII (RUSSIAN BULLETIN OF PERINATOLOGY AND PEDIATRICS) 2020. [DOI: 10.21508/1027-4065-2020-65-1-86-93] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
In the first quarter of 2019, we registered 872 cases of measles in Russia, indicating a tense epidemic situation of this disease.Purpose. To determine clinical and epidemiological features of measles in the Astrakhan region (AR) from January 2013 to April 2019.Material and methods. We analyzed 663 cases of measles confirmed by enzyme immunoassay (293 children + 370 adults) in the AR from January 2013 to April 2019. Results. We found that in the age structure of measles incidence in AO prevail patients aged from 18 to 29 years old, unvaccinated or lacking vaccination information, unvaccinated children of 1-2 years old and children under 1 year old, not subject to measles vaccination. The main reasons for the lack of vaccination in children with measles under 17 years are medical withdrawal; and among adults – insufficient vaccination of people under 35 years and the absence of vaccination in people over 35 years. The main reasons for the incidence of measles among vaccinated children and adults is the violations of vaccination, inaccuracy of official measles vaccination data, which is confirmed by serological monitoring, indicating a decrease in the seropositive individuals among vaccinated persons. The presence of measles foci and the spread of infection can be explained by nosocomial outbreaks, spread of measles in the organized groups as a result of untimely identification and isolation of patients. Measles in children and adults of different age groups, both vaccinated and unvaccinated, occurred typically with a predominance of moderate form. The Filatov – Koplik symptom, despite its detection in only 54% of patients, remains the main sign for the diagnosis of measles in the catarrhal period of the disease, and pigmentation is a sign of the past illness.
Collapse
|
3
|
Horigan V, Gale P, Kosmider RD, Minnis C, Snary EL, Breed AC, Simons RR. Application of a quantitative entry assessment model to compare the relative risk of incursion of zoonotic bat-borne viruses into European Union Member States. MICROBIAL RISK ANALYSIS 2017; 7:8-28. [PMID: 32289058 PMCID: PMC7103962 DOI: 10.1016/j.mran.2017.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/24/2017] [Revised: 09/29/2017] [Accepted: 09/29/2017] [Indexed: 06/11/2023]
Abstract
This paper presents a quantitative assessment model for the risk of entry of zoonotic bat-borne viruses into the European Union (EU). The model considers four routes of introduction: human travel, legal trade of products, live animal imports and illegal import of bushmeat and was applied to five virus outbreak scenarios. Two scenarios were considered for Zaire ebolavirus (wEBOV, cEBOV) and other scenarios for Hendra virus, Marburg virus (MARV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The use of the same framework and generic data sources for all EU Member States (MS) allows for a relative comparison of the probability of virus introduction and of the importance of the routes of introduction among MSs. According to the model wEBOV posed the highest risk of an introduction event within the EU, followed by MARV and MERS-CoV. However, the main route of introduction differed, with wEBOV and MERS-CoV most likely through human travel and MARV through legal trade of foodstuffs. The relative risks to EU MSs as entry points also varied between outbreak scenarios, highlighting the heterogeneity in global trade and travel to the EU MSs. The model has the capability to allow for a continual updating of the risk estimate using new data as, and when, it becomes available. The model provides an horizon scanning tool for use when available data are limited and, therefore, the absolute risk estimates often have high uncertainty. Sensitivity analysis suggested virus prevalence in bats has a large influence on the results; a 90% reduction in prevalence reduced the risk of introduction considerably and resulted in the relative ranking of MARV falling below that for MERS-CoV, due to this parameter disproportionately affecting the risk of introduction from the trade route over human travel.
Collapse
Affiliation(s)
- Verity Horigan
- Animal and Plant Health Agency (APHA), Department of Epidemiological Sciences, New Haw, Addlestone, Surrey KT15 3NB, United Kingdom
| | - Paul Gale
- Animal and Plant Health Agency (APHA), Department of Epidemiological Sciences, New Haw, Addlestone, Surrey KT15 3NB, United Kingdom
| | - Rowena D. Kosmider
- Animal and Plant Health Agency (APHA), Department of Epidemiological Sciences, New Haw, Addlestone, Surrey KT15 3NB, United Kingdom
| | - Christopher Minnis
- The Royal Veterinary College, Royal College Street, London, England NW1 0TU, United Kingdom
| | - Emma L. Snary
- Animal and Plant Health Agency (APHA), Department of Epidemiological Sciences, New Haw, Addlestone, Surrey KT15 3NB, United Kingdom
| | - Andrew C. Breed
- Animal and Plant Health Agency (APHA), Department of Epidemiological Sciences, New Haw, Addlestone, Surrey KT15 3NB, United Kingdom
| | - Robin R.L. Simons
- Animal and Plant Health Agency (APHA), Department of Epidemiological Sciences, New Haw, Addlestone, Surrey KT15 3NB, United Kingdom
| |
Collapse
|
4
|
Neethirajan S, Ahmed SR, Chand R, Buozis J, Nagy É. Recent Advances in Biosensor Development for Foodborne Virus Detection. Nanotheranostics 2017; 1:272-295. [PMID: 29071193 PMCID: PMC5646734 DOI: 10.7150/ntno.20301] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2017] [Accepted: 05/07/2017] [Indexed: 11/05/2022] Open
Abstract
Outbreaks of foodborne diseases related to fresh produce have been increasing in North America and Europe. Viral foodborne pathogens are poorly understood, suffering from insufficient awareness and surveillance due to the limits on knowledge, availability, and costs of related technologies and devices. Current foodborne viruses are emphasized and newly emerging foodborne viruses are beginning to attract interest. To face current challenges regarding foodborne pathogens, a point-of-care (POC) concept has been introduced to food testing technology and device. POC device development involves technologies such as microfluidics, nanomaterials, biosensors and other advanced techniques. These advanced technologies, together with the challenges in developing foodborne virus detection assays and devices, are described and analysed in this critical review. Advanced technologies provide a path forward for foodborne virus detection, but more research and development will be needed to provide the level of manufacturing capacity required.
Collapse
Affiliation(s)
- Suresh Neethirajan
- BioNano Laboratory, School of Engineering, University of Guelph, Guelph, ON N1G 2W1, Canada
| | - Syed Rahin Ahmed
- BioNano Laboratory, School of Engineering, University of Guelph, Guelph, ON N1G 2W1, Canada
| | - Rohit Chand
- BioNano Laboratory, School of Engineering, University of Guelph, Guelph, ON N1G 2W1, Canada
| | - John Buozis
- BioNano Laboratory, School of Engineering, University of Guelph, Guelph, ON N1G 2W1, Canada
| | - Éva Nagy
- Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada
| |
Collapse
|
5
|
Mekibib B, Ariën KK. Aerosol Transmission of Filoviruses. Viruses 2016; 8:v8050148. [PMID: 27223296 PMCID: PMC4885103 DOI: 10.3390/v8050148] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2015] [Revised: 05/18/2016] [Accepted: 05/20/2016] [Indexed: 12/30/2022] Open
Abstract
Filoviruses have become a worldwide public health concern because of their potential for introductions into non-endemic countries through international travel and the international transport of infected animals or animal products. Since it was first identified in 1976, in the Democratic Republic of Congo (formerly Zaire) and Sudan, the 2013–2015 western African Ebola virus disease (EVD) outbreak is the largest, both by number of cases and geographical extension, and deadliest, recorded so far in medical history. The source of ebolaviruses for human index case(s) in most outbreaks is presumptively associated with handling of bush meat or contact with fruit bats. Transmission among humans occurs easily when a person comes in contact with contaminated body fluids of patients, but our understanding of other transmission routes is still fragmentary. This review deals with the controversial issue of aerosol transmission of filoviruses.
Collapse
Affiliation(s)
- Berhanu Mekibib
- Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Nationalestraat 155, Antwerp B-2000, Belgium.
- School of Veterinary Medicine, College of Natural and Computational Sciences, Hawassa University, P.O. Box 05, Hawassa, Ethiopia.
| | - Kevin K Ariën
- Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Nationalestraat 155, Antwerp B-2000, Belgium.
| |
Collapse
|
6
|
Mann E, Streng S, Bergeron J, Kircher A. A Review of the Role of Food and the Food System in the Transmission and Spread of Ebolavirus. PLoS Negl Trop Dis 2015; 9:e0004160. [PMID: 26633305 PMCID: PMC4669147 DOI: 10.1371/journal.pntd.0004160] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
The current outbreak of Ebola virus disease (EVD) centered in West Africa is the largest in history, with nearly ten times more individuals contracting the disease than all previous outbreaks combined. The details of human-to-human and zoonotic ebolavirus transmission have justifiably received the largest share of research attention, and much information exists on these topics. However, although food processing-in the form of slaughtering and preparing wildlife for consumption (referred to as bushmeat)-has been implicated in EVD outbreaks, the full role of food in EVD spread is poorly understood and has been little studied. A literature search was undertaken to assess the current state of knowledge regarding how food can or may transmit ebolaviruses and how the food system contributes to EVD outbreak and spread. The literature reveals surprising preliminary evidence that food and the food system may be more implicated in ebolavirus transmission than expected and that further research is urgently needed.
Collapse
Affiliation(s)
- Erin Mann
- Food Protection and Defense Institute, University of Minnesota, Saint Paul, Minnesota, United States of America
| | - Stephen Streng
- Food Protection and Defense Institute, University of Minnesota, Saint Paul, Minnesota, United States of America
| | - Justin Bergeron
- Food Protection and Defense Institute, University of Minnesota, Saint Paul, Minnesota, United States of America
| | - Amy Kircher
- Food Protection and Defense Institute, University of Minnesota, Saint Paul, Minnesota, United States of America
| |
Collapse
|
7
|
Groseth A, Marzi A, Hoenen T, Herwig A, Gardner D, Becker S, Ebihara H, Feldmann H. The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLoS Pathog 2012; 8:e1002847. [PMID: 22876185 PMCID: PMC3410889 DOI: 10.1371/journal.ppat.1002847] [Citation(s) in RCA: 76] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2012] [Accepted: 06/22/2012] [Indexed: 12/28/2022] Open
Abstract
Among the Ebola viruses most species cause severe hemorrhagic fever in humans; however, Reston ebolavirus (REBOV) has not been associated with human disease despite numerous documented infections. While the molecular basis for this difference remains unclear, in vitro evidence has suggested a role for the glycoprotein (GP) as a major filovirus pathogenicity factor, but direct evidence for such a role in the context of virus infection has been notably lacking. In order to assess the role of GP in EBOV virulence, we have developed a novel reverse genetics system for REBOV, which we report here. Together with a previously published full-length clone for Zaire ebolavirus (ZEBOV), this provides a unique possibility to directly investigate the role of an entire filovirus protein in pathogenesis. To this end we have generated recombinant ZEBOV (rZEBOV) and REBOV (rREBOV), as well as chimeric viruses in which the glycoproteins from these two virus species have been exchanged (rZEBOV-RGP and rREBOV-ZGP). All of these viruses could be rescued and the chimeras replicated with kinetics similar to their parent virus in tissue culture, indicating that the exchange of GP in these chimeric viruses is well tolerated. However, in a mouse model of infection rZEBOV-RGP demonstrated markedly decreased lethality and prolonged time to death when compared to rZEBOV, confirming that GP does indeed contribute to the full expression of virulence by ZEBOV. In contrast, rREBOV-ZGP did not show any signs of virulence, and was in fact slightly attenuated compared to rREBOV, demonstrating that GP alone is not sufficient to confer a lethal phenotype or exacerbate disease in this model. Thus, while these findings provide direct evidence that GP contributes to filovirus virulence in vivo, they also clearly indicate that other factors are needed for the acquisition of full virulence.
Collapse
Affiliation(s)
- Allison Groseth
- Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America
- Institut für Virologie, Philipps Universität Marburg, Marburg, Germany
- Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
- Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada
| | - Andrea Marzi
- Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America
- Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
| | - Thomas Hoenen
- Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America
- Institut für Virologie, Philipps Universität Marburg, Marburg, Germany
- Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
| | - Astrid Herwig
- Institut für Virologie, Philipps Universität Marburg, Marburg, Germany
| | - Don Gardner
- Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America
| | - Stephan Becker
- Institut für Virologie, Philipps Universität Marburg, Marburg, Germany
| | - Hideki Ebihara
- Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America
- Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
| | - Heinz Feldmann
- Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America
- Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
- Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada
| |
Collapse
|